Fig. 2From: Preclinical assessment of intravitreal ramucirumab: in vitro and in vivo safety profileEffects of ramucirumab on ARPE-19 cells. Cells were incubated in the presence of ramucirumab at 10, 25, 50, 100, 200, 250 and 500 µg/well for 2 h. The MTT assay was performed to evaluate cell viability. The experiments were performed in triplicate and repeated three timesBack to article page